Inventor
VALENZANO KENNETH
US11 patents
⚠️ This page may combine multiple inventors who share the name “VALENZANO KENNETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMICUS THERAPEUTICS INC
9 patentsUS10357548B2Jul 23, 2019
α-galactosidase A and 1-deoxygalactonojirimycin co-formulation
AMICUS THERAPEUTICS INC49 citations95
US10155027B2Dec 18, 2018
Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease
AMICUS THERAPEUTICS INC49 citations92
US9303249B2Apr 5, 2016
High concentration α-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC15 citations92
US10512677B2Dec 24, 2019
High concentration alpha-glucosidase compositions for the treatment of pompe disease
AMICUS THERAPEUTICS INC4 citations83
US10046033B2Aug 14, 2018
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC4 citations83
US12419937B2Sep 23, 2025
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US11278599B2Mar 22, 2022
High concentration alpha-glucosidase compositions for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US9931353B2Apr 3, 2018
Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases
AMICUS THERAPEUTICS INC0 citations51
US9937165B2Apr 10, 2018
Pharmacological chaperones for treating obesity
AMICUS THERAPEUTICS INC0 citations50